Cite
MLA Citation
A.A. Bokhari et al.. “Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC.” Lung cancer, vol. 171, 2022, pp. 103–114. http://access.bl.uk/ark:/81055/vdc_100161683945.0x00004b